Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 386,349 | 128,455 | 792,739 | 517,926 | 358,522 |
| Depreciation Amortization | 968,631 | 556,359 | 1,896,158 | 1,443,259 | 950,834 |
| Income taxes - deferred | -97,488 | -48,167 | -132,202 | -97,429 | -63,827 |
| Accounts receivable | -606,929 | -600,089 | -164,341 | -82,757 | -30,559 |
| Accounts payable and accrued liabilities | 2,182 | -15,521 | -11,803 | -28,844 | -19,029 |
| Other Working Capital | -330,865 | -456,896 | 607,469 | 477,844 | 120,755 |
| Other Operating Activity | 291,663 | 574,078 | -142,870 | -151,443 | -62,761 |
| Operating Cash Flow | $613,543 | $138,218 | $2,845,151 | $2,078,556 | $1,253,937 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -304,333 | -140,592 | -723,472 | -467,566 | -322,581 |
| Net Acquisitions | 533,297 | 44,057 | 148,274 | 4,877 | 12,063 |
| Purchase Of Investment | -529 | -204 | -110,788 | -106,812 | -68,120 |
| Sale Of Investment | 45,299 | 22,513 | 96,969 | 82,196 | 55,200 |
| Investing Cash Flow | $273,734 | $-74,226 | $-589,017 | $-487,305 | $-323,437 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 207,283 | 12,491 | 70,714 | 411,401 | 807,079 |
| Debt Issued | 26,772 | 10,084 | 452,268 | 229,181 | 10,374 |
| Debt Repayment | -248,794 | -17,854 | -758,328 | -38,310 | -26,603 |
| Dividend Paid | -470,477 | -61,829 | -694,824 | -612,631 | -528,434 |
| Other Financing Activity | -728,482 | -257,373 | -1,081,317 | -1,200,895 | -1,026,291 |
| Financing Cash Flow | $-1,213,699 | $-314,481 | $-2,011,486 | $-1,211,253 | $-763,874 |
| Exchange Rate Effect | -13,175 | -4,901 | -78,583 | -52,855 | -71,204 |
| Beginning Cash Position | 1,536,979 | 1,549,538 | 1,378,620 | 1,386,390 | 1,388,937 |
| End Cash Position | 1,197,382 | 1,294,149 | 1,544,686 | 1,713,532 | 1,484,359 |
| Net Cash Flow | $-339,596 | $-255,389 | $166,066 | $327,143 | $95,422 |
| Free Cash Flow | |||||
| Operating Cash Flow | 613,543 | 138,218 | 2,845,151 | 2,078,556 | 1,253,937 |
| Capital Expenditure | -315,873 | -145,375 | -740,938 | -472,712 | -324,435 |
| Free Cash Flow | 297,670 | -7,157 | 2,104,213 | 1,605,844 | 929,502 |